Search research articles
Contact Us
Filters
Showing results (641-650 of 653) with videos related to
Page
of 66
Sort By:
Journal for Immunotherapy of Cancer
|
March 22, 2023
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
Karen A Autio, Celestia S Higano, Luke Nordquist, et al.
Psychological Medicine
|
September 15, 2012
Persistent infection with neurotropic herpes viruses and cognitive impairment
A M M Watson, K M Prasad, L Klei, et al.
Public Health Action
|
July 27, 2017
Data collection using open access technology in multicentre operational research involving patient interviews
, H D Shewade, S S Chadha, et al.
The New England Journal of Medicine
|
November 15, 2022
IARC Perspective on Oral Cancer Prevention
Véronique Bouvard, Suzanne T Nethan, Deependra Singh, et al.
Science Translational Medicine
|
July 26, 2013
CaMKII is essential for the proasthmatic effects of oxidation
Philip N Sanders, Olha M Koval, Omar A Jaffer, et al.
Journal of Clinical and Experimental Hepatology
|
February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study
Narendra S Choudhary, Ajay Duseja, Arka De, et al.
Open Biology
|
June 18, 2024
A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex
Maya Michon, Andreas Müller-Schiffmann, Anuradha F Lingappa, et al.
Plos One
|
August 8, 2022
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, et al.
Plos One
|
April 4, 2025
Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, et al.
Lancet (London, England)
|
September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
, Christopher J L Murray, Ryan M Barber, et al.
Page
of 66
Search research articles
Search
Showing results (641-650 of 653) with videos related to
Sort By:
Page
of 66
Journal for Immunotherapy of Cancer
|
March 22, 2023
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
Karen A Autio, Celestia S Higano, Luke Nordquist, et al.
Psychological Medicine
|
September 15, 2012
Persistent infection with neurotropic herpes viruses and cognitive impairment
A M M Watson, K M Prasad, L Klei, et al.
Public Health Action
|
July 27, 2017
Data collection using open access technology in multicentre operational research involving patient interviews
, H D Shewade, S S Chadha, et al.
The New England Journal of Medicine
|
November 15, 2022
IARC Perspective on Oral Cancer Prevention
Véronique Bouvard, Suzanne T Nethan, Deependra Singh, et al.
Science Translational Medicine
|
July 26, 2013
CaMKII is essential for the proasthmatic effects of oxidation
Philip N Sanders, Olha M Koval, Omar A Jaffer, et al.
Journal of Clinical and Experimental Hepatology
|
February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study
Narendra S Choudhary, Ajay Duseja, Arka De, et al.
Open Biology
|
June 18, 2024
A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex
Maya Michon, Andreas Müller-Schiffmann, Anuradha F Lingappa, et al.
Plos One
|
August 8, 2022
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, et al.
Plos One
|
April 4, 2025
Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, et al.
Lancet (London, England)
|
September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
, Christopher J L Murray, Ryan M Barber, et al.
Page
of 66